Increased Prevalence of Psychopathology and Maladaptive Personality Traits after Long-Term Cure of Cushing’s Disease
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: Psychopathology and maladaptive personality traits are often observed during the active phase of Cushing's disease (CD). We hypothesized that patients with long-term cure of CD show persistent psychopathology and maladaptive personality traits. DESIGN: Four questionnaires on frequently occurring psychopathology in somatic illnesses were used, including the Apathy Scale, Irritability Scale, Hospital Anxiety and Depression Scale, and Mood and Anxiety Symptoms Questionnaire short-form. Personality was assessed using the Dimensional Assessment of Personality Pathology short-form (DAPPs). PATIENTS AND CONTROL SUBJECTS: We included 51 patients cured of CD (16% men, 53 ± 13 yr) and 51 matched controls. In addition, we included 55 patients treated for nonfunctioning pituitary macroadenomas (55% men, 62 ± 10 yr), and 55 matched controls. RESULTS: Mean duration of remission was 11 yr (range 1-32 yr). Compared with matched controls, patients cured from CD scored significantly worse on virtually all questionnaires. Compared with nonfunctioning pituitary macroadenoma patients, patients treated for CD scored worse on apathy (P < 0.001), irritability (P < 0.001), anxiety (P < 0.001), negative affect and lack of positive affect (P < 0.001 on both scales), somatic arousal (P < 0.001), and 11 of 18 subscales of the Dimensional Assessment of Personality Pathology short-form (P < 0.05). CONCLUSIONS: Patients with long-term cured CD show an increased prevalence of psychopathology and maladaptive personality traits. These observations suggest irreversible effects of previous glucocorticoid excess on the central nervous system rather than an effect of pituitary tumors and/or their treatment in general. This may also be of relevance for patients treated with high doses of exogenous glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term effects of postnatal GC on the human brain include decreased memory and hippocampal volume (145), decreased cerebellar cortical volume (146), diminished cognitive function (147-149), increased psychopathology, and reduced QOL (148, 150)”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [150]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications
Clark, L. A., & Watson, D. (1991) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.100.3.316 · Cited by 4,601 · cited 1×
“There are no formal cutoff scores (15).”
SPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158 · cited 1×
“A score greater than 8 points on one of the subscales is being used to characterize subjects as being anxious or depressed respectively (13, 14).”
MethodSyndromic Validity of Apathy in Alzheimer’s Disease
Starkstein, S. E., Petracca, G., Chemerinski, E., & Kremer, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.872 · Cited by 392 · cited 2×
“A total score of 14 points or more is being used to characterize subjects as apathetic (11, 12).”
BackgroundStarkman, M. N., Schteingart, D. E., & Schork, A. M. (1981) · Psychosomatic Medicine · doi:10.1097/00006842-198102000-00002 · Cited by 289 · cited 1×
“Psychopathology is reported to be present in the majority of patients with active Cushing’s disease (17).”
BackgroundSonino, N., & Fava, G. A. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00003 · Cited by 267 · cited 5×
“019] remained significantly different between patients and controls, whereas the traits identity problems [F (1) 3.”
BackgroundMethodInfluentialDorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260 · cited 2×
“of these patients (2, 3, 24), and the prevalence of overall psychopathology decreases to 24% of the patients within 1 yr after appropriate treatment of active Cushing’s disease (21, 22).”
BackgroundResultQuality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 253 · cited 1×
“However, these patients do not completely return to their premorbid level of functioning, and persistently impaired quality of life has been reported despite long-term cure (4).”
BackgroundEffects of Glucocorticoids on Mood, Memory, and the Hippocampus: Treatment and Preventive Therapy
Brown, E. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04981.x · Cited by 214 · cited 1×
“or exogenous exposure to glucocorticoids may have longlasting adverse effects on behavioral and cognitive functions due to functional and, over time, structural alterations in specific brain target areas (8, 9).”
BackgroundPereira, A. M., van Aken, M. O., van Dulken, H., Schutte, P. J., Biermasz, N. R., Smit, J. W. A., Roelfsema, F., & Romijn, J. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030751 · Cited by 173 · cited 5×
“80 Medium: 13 Medium: 16 High: 18 High: 17 Surgery, n (%) 51 (100%) NA NA Postoperative radiotherapy, n (%) 11 (22%) NA NA Duration of remission (yr) 11 (9) NA NA Duration of follow-up (yr) 14 (10) NA NA Hypopituitarism, n (%) Any axis: 31 (61%) NA NA GH: 20 (39%) LH/FSH: 14 (28%) TSH: 21 (41%) ADH: 10 (20%) Hydrocort…”
BackgroundInfluential
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Finally, in this guideline, we discuss potential new therapies and future ways to improve quality of life (QOL) for individuals with CAH.”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Dynamics of ACTH and Cortisol Secretion and Implications for Disease
Lightman, S. L., Birnie, M. T., & Conway-Campbell, B. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa002 · Cited by 439
Cortisol and depression: three questions for psychiatry
Herbert, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712000955 · Cited by 301
“Reexamining recovered Cushing’s patients in the expectation that they return to a basal, pre-morbid state is vitiated by knowledge that recovery is often incomplete and the effects of hypercortisolaemia are prolonged (Pereira et al. 2010 ; Tiemensma et al. 2010).”
BackgroundFeelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
The Neuropsychiatric Complications of Glucocorticoid Use: Steroid Psychosis Revisited
Dubovsky, A. N., Arvikar, S., Stern, T. A., & Axelrod, L. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.12.007 · Cited by 244
Cushing’s disease: the burden of illness
Pivonello, R., De Martino, M. C., De Leo, M., Simeoli, C., & Colao, A. (2017) · Endocrine · doi:10.1007/s12020-016-0984-8 · Cited by 171
“However, it has been shown that even after long-term surgical cure of Cushing’s disease, patients exhibit an increased prevalence of psychopathology and maladaptive personality traits [40], particularly those associated with anxiety [41].”
BackgroundAndela, C. D., van Haalen, F. M., Ragnarsson, O., Papakokkinou, E., Johannsson, G., Santos, A., Webb, S. M., Biermasz, N. R., van der Wee, N. J. A., & Pereira, A. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1101 · Cited by 164
Self-citationHypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment
van der Pas, R., Leebeek, F. W. G., Hofland, L. J., de Herder, W. W., & Feelders, R. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12094 · Cited by 162
Andela, C. D., Scharloo, M., Pereira, A. M., Kaptein, A. A., & Biermasz, N. R. (2015) · Pituitary · doi:10.1007/s11102-015-0636-7 · Cited by 142
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
Vives, A. S., Resmini, E., Pascual, J. C., Crespo, I., & Webb, S. M. (2017) · Drugs · doi:10.1007/s40265-017-0735-z · Cited by 146
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1945 · Cited by 111
“Psychopathology (15, 16) and fatigue (17, 18) are com-”
Backgroundvan Haalen, F. M., Broersen, L. H. A., Jorgensen, J. O., Pereira, A. M., & Dekkers, O. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0556 · Cited by 103
Self-citationComorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 101
“irreversible effects of cortisol excess on the central nervous system rather than an effect of pituitary tumors or their treatment [46].”
BackgroundAndela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van den Berg, S. M., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Romijn, J. A., Tiemensma, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0471 · Cited by 102
Evaluation of depression, quality of life and body image in patients with Cushing’s disease
Alçalar, N., Ozkan, S., Kadıoğlu, P., Celik, O., Çağatay, P., Küçükyürük, B., & Gazioğlu, N. (2012) · Pituitary · doi:10.1007/s11102-012-0425-5 · Cited by 95
“[25] reported that patients with long-term cure of CD suffer from more psychopathology and maladaptive personality traits compared to matched controls and nonfunctioning pituitary macroadenomas.”
Backgroundvan der Werff, S. J. A., Andela, C. D., Nienke Pannekoek, J., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., Pereira, A. M., & van der Wee, N. J. A. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.01.017 · Cited by 92
“The total score of the active phase and the total score of the remission phase were used in the analyses.”
MethodQuality of life in Cushing’s syndrome
Vives, A. S., Crespo, I., Aulinas, A., Resmini, E., Valassi, E., & Webb, S. M. (2015) · Pituitary · doi:10.1007/s11102-015-0640-y · Cited by 96
Long‐term morbidity and mortality in patients with Cushing's syndrome
Braun, L. T., Vogel, F., & Reincke, M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13113 · Cited by 86
Tiemensma, J., Kaptein, A. A., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Biermasz, N. R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0307 · Cited by 87
Andela, C. D., Niemeijer, N. D., Scharloo, M., Tiemensma, J., Kanagasabapathy, S., Pereira, A. M., Kamminga, N. G. A., Kaptein, A. A., & Biermasz, N. R. (2014) · Pituitary · doi:10.1007/s11102-014-0561-1 · Cited by 74
“The diagnosis and state of biochemical remission were confirmed in all patients, following previously described criteria [7, 39–41].”
Tiemensma, J., Andela, C. D., Kaptein, A. A., Romijn, J. A., van der Mast, R. C., Biermasz, N. R., & Pereira, A. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0023 · Cited by 73
Coping Strategies in Patients after Treatment for Functioning or Nonfunctioning Pituitary Adenomas
Tiemensma, J., Kaptein, A. A., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Biermasz, N. R. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2490 · Cited by 72
“Patients after long-term remission of Cushing’s disease suffer from subtle cognitive impairments, increased prevalence of psychopathology, and an increased incidence of maladaptive personality traits (7, 15).”
BackgroundMethodTiemensma, J., Biermasz, N. R., van der Mast, R. C., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1253 · Cited by 72
Anxiety, depression and personality traits in severe, prednisone-dependent asthma
Amelink, M., Hashimoto, S., Spinhoven, P., Pasma, H. R., Sterk, P. J., Bel, E. H., & ten Brinke, A. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2013.12.012 · Cited by 68
“This result is consistent with the observation of an increased prevalence of psychopathology in patients with long-term cured Cushing’s disease, suggesting irreversible effects of previous glucocorticoid excess on the central nervous system [39].”
ResultNieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 90
“This residual neuropsychiatric morbidity, coupled with maladaptive personality traits and negative illness perception, substantially contributes to persistently poor physical and psychosocial QoL domains, which are associated with high adverse socioeconomic effects 238,239 .”
Psychiatric and neurocognitive consequences of endogenous hypercortisolism
Piasecka, M., Papakokkinou, E., Valassi, E., Vives, A. S., Webb, S. M., de Vries, F., Pereira, A. M., & Ragnarsson, Ó. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13056 · Cited by 79
Anderson, R. M., Glanz, R. M., Johnson, S. B., Miller, M. M., Romig‐Martin, S. A., & Radley, J. J. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.24027 · Cited by 61
The risks of overlooking the diagnosis of secreting pituitary adenomas
Brue, T. C., & Castinetti, F. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0516-x · Cited by 75
“However, abnormalities in grey and white matter are not completely reversible and are associated with persistent psychological symptoms and impairments in cognitive functioning [165, 167].”
BackgroundFactors predicting long-term comorbidities in patients with Cushing's syndrome in remission
Schernthaner-Reiter, M. H., Siess, C., Gessl, A., Scheuba, C., Wolfsberger, S., Riss, P., Knosp, E., Luger, A., & Vila, G. (2019) · Endocrine · doi:10.1007/s12020-018-1819-6 · Cited by 60
Clinical consequences of Cushing’s syndrome
Valassi, E., Crespo, I., Vives, A. S., & Webb, S. M. (2012) · Pituitary · doi:10.1007/s11102-012-0394-8 · Cited by 65
“estingly, duration of remission was associated with more severe depression and negative affect [53].”
BackgroundResultValassi, E., Feelders, R., Maiter, D., Chanson, P., Yaneva, M., Reincke, M., Krsek, M., Tóth, M., Webb, S. M., Santos, A., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13600 · Cited by 59
Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing’s Disease
van der Werff, S. J. A., Pannekoek, J. N., Andela, C. D., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., Pereira, A. M., & van der Wee, N. J. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.38 · Cited by 60
“…psychiatric symptoms decrease, but patients still show cogni¬tive impairment (Dorn and Cerrone, 2000; Forget et al., 2002; Merke et al., 2005; Tiemensma et al., 2010b; Resmini et al., 2012), decreased quality of life (Tiemensma et al., 2011), and a higher prevalence of affective disorders…”
BackgroundImpaired decision‐making and selective cortical frontal thinning in Cushing's syndrome
Crespo, I., Esther, G., Santos, A., Valassi, E., Yolanda, V., De Juan‐Delago, M., Webb, S. M., Gómez‐Ansón, B., & Resmini, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12564 · Cited by 54
Long-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Pituitary adenomas and neuropsychological status: a systematic literature review
Pertichetti, M., Serioli, S., Belotti, F., Mattavelli, D., Schreiber, A., Cappelli, C., Padovani, A., Gasparotti, R., Nicolai, P., Fontanella, M. M., et al. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01134-z · Cited by 60
Ragnarsson, O., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0534 · Cited by 51
Leistner, S., Klotsche, J., Dimopoulou, C., Athanasoulia, A. P., Roemmler-Zehrer, J., Pieper, L., Schopohl, J., Wïttchen, H., Stalla, G. K., Fulda, S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0941 · Cited by 51
MANAGEMENT OF ENDOCRINE DISEASE: Quality of life tools for the management of pituitary disease
Webb, S. M., Crespo, I., Vives, A. S., Resmini, E., Aulinas, A., & Valassi, E. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0041 · Cited by 56
Quality of Life in Patients With Cushing's Disease
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Valassi, E., Martel‐Duguech, L., & Webb, S. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00862 · Cited by 78
“Anxiety is also more prevalent in CS than in healthy population, as evidenced with questionnaires like STAI (51).”
BackgroundMethodMortality in Patients with Endogenous Cushing’s Syndrome
Javanmard, P., Duan, D., & Geer, E. B. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.02.005 · Cited by 46
Maaren, Y. W. M. S.-V., Carlier, I. V. E., Zitman, F. G., van Hemert, A. M., de Waal, M. W. M., van Noorden, M. S., & Giltay, E. J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-203 · Cited by 46
Altered neural processing of emotional faces in remitted Cushing's disease
Bas-Hoogendam, J. M., Andela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van Steenbergen, H., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.001 · Cited by 44
Nonhuman Primate Models of Depression: Effects of Early Experience and Stress
Worlein, J. M. (2014) · ILAR Journal · doi:10.1093/ilar/ilu030 · Cited by 43
Broersen, L. H. A., Andela, C. D., Dekkers, O. M., Pereira, A. M., & Biermasz, N. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01054 · Cited by 42
Dimopoulou, C., Ising, M., Pfister, H., Schopohl, J., Stalla, G. K., & Sievers, C. (2012) · Neuroendocrinology · doi:10.1159/000338408 · Cited by 41
West, S., & Kenedi, C. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000065 · Cited by 44
“[14] showed an increased rate of psychopathologies compared with”
ResultCortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease
van der Pas, R., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., de Jong, F. H., van der Lely, A. J., de Herder, W. W., et al. (2013) · Pituitary · doi:10.1007/s11102-012-0452-2 · Cited by 39
“tioning appear to be partially irreversible in patients with CS even after long-term cure [7, 10, 38].”
BackgroundHippocampal and cerebellar atrophy in patients with Cushing’s disease
Burkhardt, T., Lüdecke, D., Spies, L., Wittmann, L., Westphal, M., & Flitsch, J. (2015) · Neurosurgical FOCUS · doi:10.3171/2015.8.focus15324 · Cited by 42
Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome
Santos, A., Resmini, E., Gómez-Ansón, B., Crespo, I., Granell, E., Valassi, E., Pires, P., Vives-Gilabert, Y., Martínez-Momblán, M. A., de Juan, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0600 · Cited by 37
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
Keil, M. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1123 · Cited by 45
Valassi, E., Crespo, I., Keevil, B. G., Aulinas, A., Urgell, E., Vives, A. S., Trainer, P. J., & Webb, S. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0779 · Cited by 46
Milian, M., Teufel, P., Honegger, J. B., Gallwitz, B., Schnauder, G., & Psaras, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04191.x · Cited by 38
Tiemensma, J., Daskalakis, N. P., van der Veen, E. M., Ramondt, S., Richardson, S. K., Broadbent, E., Romijn, J. A., Pereira, A. M., Biermasz, N. R., & Kaptein, A. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1235 · Cited by 38
Athanasoulia, A. P., Ising, M., Pfister, H., Mantzoros, C. S., Stalla, G. K., & Sievers, C. (2012) · Neuroendocrinology · doi:10.1159/000335996 · Cited by 36
Chan, L. F., Vaidya, M., Westphal, B., Allgrove, J., Martin, L., Afshar, F., Hindmarsh, P. C., Savage, M. O., Grossman, A. B., & Storr, H. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324419 · Cited by 37
Structural brain abnormalities in Cushing's syndrome
Bauduin, S., van der Wee, N. J. A., & van der Werff, S. J. A. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000414 · Cited by 37
Quality of life in Cushing’s syndrome
Bride, M. M., Crespo, I., Webb, S. M., & Valassi, E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101505 · Cited by 36
Quality of Life in Cushing's disease: A long term issue?
Webb, S. M., Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Martel‐Duguech, L., & Valassi, E. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.007 · Cited by 38
van Haalen, F. M., van Dijk, E. H. C., Andela, C. D., Dijkman, G., Biermasz, N. R., Pereira, A. M., & Boon, C. J. F. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13952 · Cited by 31
“The same cohort of patients with Cushing’s disease was used for the comparison of the AS and IS scores (Tiemensma et al. 2010a,b).”
BackgroundMethodInfluentialMorbidity of Cushing’s Syndrome and Impact of Treatment
Webb, S. M., & Valassi, E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.001 · Cited by 41
Bengtsson, D., Ragnarsson, Ó., Berinder, K., Dahlqvist, P. M., Engström, B. E., Ekman, B., Höybye, C., Burman, P., & Wahlberg, J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab079 · Cited by 34
“Antidiabetics including insulin 9 (16) 4 (1.”
BackgroundResultInfluentialVives, A. S., Granell, E., Gómez‐Ansón, B., Crespo, I., Pires, P., Vives‐Gilabert, Y., Valassi, E., Webb, S. M., & Resmini, E. (2017) · BioMed Research International · doi:10.1155/2017/2061935 · Cited by 36
Mental Fatigue and Executive Dysfunction in Patients with Cushing’s Syndrome in Remission
Papakokkinou, E., Johansson, B., Berglund, P., & Ragnarsson, O. (2015) · Behavioural Neurology · doi:10.1155/2015/173653 · Cited by 29
“Compared to patients treated for nonfunctioning pituitary adenomas, patients with CD in remission perform worse in certain aspects of executive functioning and memory and report a higher prevalence of psychopathology [6, 16].”
BackgroundNeuropsychiatric disorders and cognitive dysfunction in patients with Cushing's disease
Chen, Y., Li, Y., Xiao, C. H. E. N., & Sun, Q. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20130944 · Cited by 31
The partner’s perspective of the impact of pituitary disease: Looking beyond the patient
Andela, C. D., Tiemensma, J., Kaptein, A. A., Scharloo, M., Pereira, A. M., Kamminga, N. G. A., & Biermasz, N. R. (2017) · Journal of Health Psychology · doi:10.1177/1359105317695427 · Cited by 27
“The limitation of research reflexivity could potentially be found in the previous research by our research group into the psychosocial impact of pituitary disease (Andela et al., 2015a, 2015b; Tiemensma et al., 2010a, 2010b, 2011; Van der Klaauw et al., 2008).”
ResultPredictors of quality of life in 102 patients with treated C ushing's disease
Carluccio, A. L., Sundaram, N. K., Chablani, S. V., Amrock, L. G., Lambert, J. K., Post, K. D., & Geer, E. B. (2014) · Clinical Endocrinology · doi:10.1111/cen.12521 · Cited by 33
Clinical and biochemical manifestations of Cushing’s
Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · Pituitary · doi:10.1007/s11102-014-0631-4 · Cited by 33
Milian, M., Honegger, J. B., Teufel, P., Wolf, A., & Psaras, T. (2013) · Neuroendocrinology · doi:10.1159/000355622 · Cited by 25
Crespo, I., Vives, A. S., Gómez‐Ansón, B., López‐Mourelo, O., Pires, P., Vives‐Gilabert, Y., Webb, S. M., & Resmini, E. (2016) · Endocrine · doi:10.1007/s12020-016-0963-0 · Cited by 28
Laura, E., Sosa, E., Nayeli, M., & Moisés, M. (2013) · Endocrine Practice · doi:10.4158/ep12247.or · Cited by 23
Syndromes de Cushing : physiopathologie, étiologie et principes thérapeutiques
Chabre, O. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.001 · Cited by 21
“Cependant, il est maintenant établi qu’il n’y a pas de retour parfait à la normale, en termes de morbidité cardiovasculaire [52], de qualité de vie [6], de masse musculaire [53], de lithiase urinaire [54], de retentissement neuro-psychique sur les fonctions cognitives [55,56].”
Using subscales when scoring the Cushing's quality of life questionnaire
Tiemensma, J., Depaoli, S. A., & Felt, J. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0640 · Cited by 23
Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome
Keil, M. F., Zametkin, A. J., Ryder, C., Lodish, M. B., & Stratakis, C. A. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2234 · Cited by 24
Pronóstico del paciente tratado de síndrome de Cushing
Aulinas, A., Valassi, E., & Webb, S. M. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.03.008 · Cited by 21
Psychological complications of Cushing's syndrome
Vives, A. S., Webb, S. M., & Resmini, E. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000633 · Cited by 24
“unknown, chronic hypercortisolism itself could play an important role, as chronic exposure to stressors is considered a risk factor for psychiatric disorders [4,5].”
BackgroundCortical thickness abnormalities in long-term remitted Cushing’s disease
Bauduin, S., van der Pal, Z., Pereira, A. M., Meijer, O. C., Giltay, E. J., van der Wee, N. J. A., & van der Werff, S. J. A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00980-6 · Cited by 18
Stress, Affective Status and Neurodegenerative Onslaughts
Archer, T., & Rapp‐Ricciardi, M. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-90065-0_3 · Cited by 17
Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome
Moeller, S. J., Couto, L., Cohen, V. V., Lalazar, Y., Makotkine, I., Williams, N., Yehuda, R., Goldstein, R. Z., & Geer, E. B. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00021 · Cited by 18
“In all ANCOVAs and follow-up comparisons, p < 0.05 was considered significant.”
InfluentialCharacterization of persistent and recurrent Cushing’s disease
Sundaram, N. K., Carluccio, A. L., & Geer, E. B. (2013) · Pituitary · doi:10.1007/s11102-013-0511-3 · Cited by 19
Functional brain alterations in Cushing’s syndrome
Papakokkinou, E., & Ragnarsson, Ó. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1163482 · Cited by 20
“Moreover, it has previously been shown that patients with CS have impaired memory, concentration, attention as well as higher scores on the apathy scale (11, 12, 30).”
BackgroundPsychological well-being and illness perceptions in patients with hypopituitarism
Slagboom, T. N. A., Deijen, J. B., van Bunderen, C. C., Knoop, H., & Drent, M. L. (2021) · Pituitary · doi:10.1007/s11102-021-01131-w · Cited by 16
Durcan, E., Turan, Ş., Şahin, S., Sulu, C., Taze, S. S., Kavla, Y., Özkaya, H. M., & Kadıoğlu, P. (2021) · Pituitary · doi:10.1007/s11102-021-01136-5 · Cited by 16
“As for patients with CD, anxiety rates varying between 12% [31] and 66% [32] were reported in patients with active CD, and a rate of 20% was reported for those in remission [33].”
BackgroundNeuropsychological and Emotional Functioning in Patients with Cushing’s Syndrome
Na, S. D., Fernandes, M. A., Ioachimescu, A. G., & Penna, S. (2020) · Behavioural Neurology · doi:10.1155/2020/4064370 · Cited by 16
Carlier, I. V. E., Colijn, S., van Rood, Y. R., Streevelaar, M. F., van Vliet, I. M., & van Veen, T. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.012 · Cited by 18
“In general, the Dutch version of the DAPP-SF has good psychometric properties (van Kampen et al., 2008; de Beurs et al., 2009; Tiemensma et al., 2010a,2010b).”
BackgroundSleep disruption in patients with active and treated endogenous Cushing’s syndrome
Geer, E. B., Grillo, I., Li, Q., Robins, H., Cohen, V. V., Baratz, H. Q., Garcia, C., Sazo, M., Lin, A. L., Cohen, M. A., et al. (2024) · Pituitary · doi:10.1007/s11102-024-01450-8 · Cited by 15
“Research characterizing the extent and quality of sleep disturbances in CS has been limited, and it is not clear if successful treatment can reverse or even improve impaired sleep in CS patients [3, 7, 10–12].”
BackgroundMilian, M., Honegger, J. B., Gerlach, C., Hemeling, X., & Psaras, T. (2014) · Neuroendocrinology · doi:10.1159/000364878 · Cited by 16
van Trigt, V. R., Andela, C. D., Bakker, L. E. H., Brama, S. C. M., Schmidt, L. E., Sneekes, F. M., Zeelenberg, M. W., Huisman, S. D., Bauduin, S., Dekkers, O. M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf355 · Cited by 10
Prognosis of patients treated for Cushing syndrome
Aulinas, A., Valassi, E., & Webb, S. M. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.01.004 · Cited by 13
Long-term effects of treatment of pituitary adenomas
Pereira, A. M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00024-1 · Cited by 11
Hypothalamo-Pituitary-Adrenal Axis in Depressive Disorders and Treatment Resistance
Yunilaynen, O. A., Starostina, E. G., & Oleichik, I. V. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-1-73-90 · Cited by 10
Psychopathology in Acromegaly—Real and Perceived
Pivonello, R., Neggers, S. J. C. M. M., & Imran, S. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad237 · Cited by 11
How to manage Cushing's disease after failed primary pituitary surgery
Agrawal, N., Urwyler, S. A., Mehta, S., Karavitaki, N., & Feelders, R. A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae110 · Cited by 8
Biological Indicators of Suicide Risk in Youth With Mood Disorders: What Do We Know So Far?
Lewitzka, U., Doucette, S., Seemüller, F., Grof, P., & Duffy, A. C. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0329-0 · Cited by 9
Winter, S. D., Depaoli, S. A., & Tiemensma, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00368 · Cited by 8
Cognition and psychological wellbeing in hypopituitary patients
Imran, S. A., & Wilkinson, M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09869-3 · Cited by 8
“Another study reported persistent psychopathology and maladaptive personality traits including anxiety, apathy, irritability and negative affect among CD patients in remission for over 10 years [10 ].”
Brzozowska, M. M., Kepreotis, S., Tsang, F., & Patarroyo, S. X. F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0401-4 · Cited by 9
Germann, S., Wimmer, R., Laager, R., Müeller, B., Schüetz, P., Kaegi-Braun, N., & Kutz, A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae069 · Cited by 7
Structural and functional brain alterations in Cushing’s disease: A narrative review
Liu, Y.-F., Pan, L., & Feng, M. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101033 · Cited by 8
Feng, Z., Zhang, H., Zhou, T., Yu, X., Zhang, Y., & Yan, X. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02615-y · Cited by 8
Metadata
- Authors
- Tiemensma, J., Biermasz, N. R., Middelkoop, H. A. M., van der Mast, R. C., Romijn, J. A., & Pereira, A. M.
- Affiliations
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-10
- Volume
- 95
- Issue
- 10
- Pages
- E129-E141
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2140913018
- Cited by
- 142
- References
- 29
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 8 · 2023: 9 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 5 · 2018: 13 · 2017: 6 · 2016: 13 · 2015: 14 · 2014: 14 · 2013: 13 · 2012: 15
- FWCI
- 8.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's disease, psychopathology, maladaptive personality traits, long-term remission, apathy, irritability, anxiety, negative affect, somatic arousal, glucocorticoid excess, non-functioning pituitary macroadenoma, exogenous glucocorticoids, personality pathology
- MeSH terms
- Adaptation, Psychological, Adenoma, Adult, Aged, Mental Disorders, Female, Humans, Male, Middle Aged, Personality Disorders, Pituitary Neoplasms, Psychiatric Status Rating Scales, Psychopathology, Surveys and Questionnaires, Time Factors, Prevalence, Case-Control Studies, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.